Recent studies have shown that the expression of MYOF is up‐regulated in several types of cancers, such as breast cancer, lung cancer, pancreatic adenocarcinoma and oropharyngeal squamous cell carcinoma, and high expression of MYOF is associated with poor outcome in those patients 9. Here, MYOF is linked to lung cancer.